Position in EXEL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$16,941
New position
Shares Held
395
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Destiny Wealth Partners, LLC holds $465,625 across 13 Biotechnology names. EXEL ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
247 | $190,842 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
200 | $89,308 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
2,380 | $34,414 | |
| 4 | INSM |
INSMED Inc
|
175 | $28,616 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
375 | $28,158 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
77 | $25,476 | |
| 7 | INCY |
Incyte Corp
|
185 | $17,412 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
395 | $16,941 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,941 | 395 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||